{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:16:12Z","timestamp":1759011372685,"version":"3.40.5"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Polish Ministry of Science","award":["NCN NN 402613840"],"award-info":[{"award-number":["NCN NN 402613840"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.meegid.2016.12.019","type":"journal-article","created":{"date-parts":[[2016,12,23]],"date-time":"2016-12-23T12:18:12Z","timestamp":1482495492000},"page":"122-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-1084","authenticated-orcid":false,"given":"Mi\u0142osz","family":"Parczewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Leszczyszyn-Pynka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Urba\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2016.12.019_bb0005","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1128\/JVI.03485-14","article-title":"Dolutegravir resistance mutation R263K cannot coexist in combination with many classical integrase inhibitor resistance substitutions","volume":"89","author":"Anstett","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2016.12.019_bb0010","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/jac\/dkw109","article-title":"Polymorphic substitution E157Q in HIV-1 integrase increases R263K-mediated dolutegravir resistance and decreases DNA binding activity","volume":"71","author":"Anstett","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004724","article-title":"Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update","volume":"4","author":"Bennett","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2016.12.019_bb0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3851\/IMP1749","article-title":"Transmitted raltegravir resistance in an HIV-1 CRF_AG-infected patient","volume":"16","author":"Boyd","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2016.12.019_bb0025","article-title":"Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance","volume":"12","author":"Brenner","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.meegid.2016.12.019_bb0030","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3851\/IMP3024","article-title":"Systematic review to determine the prevalence of transmitted drug resistance mutations to rilpivirine in HIV-infected treatment-naive persons","volume":"21","author":"Calvez","year":"2016","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2016.12.019_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jac\/dkp477","article-title":"Genotypic\/phenotypic patterns of HIV-1 integrase resistance to raltegravir","volume":"65","author":"Canducci","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0040","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/jac\/dkv202","article-title":"Primary resistance to integrase strand-transfer inhibitors in Europe","volume":"70","author":"Casadella","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0045","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/jac\/dku439","article-title":"High frequency of dolutegravir resistance in patients failing a raltegravir-containing salvage regimen","volume":"70","author":"Cavalcanti Jde","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0050","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1093\/nar\/gkg500","article-title":"Multiple sequence alignment with the Clustal series of programs","volume":"31","author":"Chenna","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.meegid.2016.12.019_bb0055","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/jac\/dkv012","article-title":"Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region","volume":"70","author":"Danion","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0060","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/jac\/dkv243","article-title":"Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades","volume":"70","author":"Doyle","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0065","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1093\/molbev\/mss075","article-title":"Bayesian phylogenetics with BEAUti and the BEAST 1.7","volume":"29","author":"Drummond","year":"2012","journal-title":"Mol. Biol. Evol."},{"author":"European AIDS Clinical Society","key":"10.1016\/j.meegid.2016.12.019_bb0070"},{"key":"10.1016\/j.meegid.2016.12.019_bb0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.antiviral.2011.05.011","article-title":"Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor","volume":"91","author":"Goethals","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2016.12.019_bb0080","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1310\/hct1401-10","article-title":"Prevalence of primary resistance mutations to integrase inhibitors in treatment-naive and -experienced patients infected with B and non-B HIV-1 variants","volume":"14","author":"Gutierrez","year":"2013","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.meegid.2016.12.019_bb0085","first-page":"30271","article-title":"Differences among HIV-1 subtypes in drug resistance against integrase inhibitors","volume":"25","author":"Han","year":"2016","journal-title":"Infect. Genet. Evol."},{"article-title":"The performance of ReCall basecalling software for high-throughput HIV drug resistance basecalling using \u201cin-house\u201d methods","year":"2002","author":"Harrigan PR","key":"10.1016\/j.meegid.2016.12.019_bb0090"},{"key":"10.1016\/j.meegid.2016.12.019_bb0095","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/QAI.0b013e3181c42ea4","article-title":"Evolution of integrase resistance during failure of integrase inhibitor-based antiretroviral therapy","volume":"54","author":"Hatano","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.meegid.2016.12.019_bb0100","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/cid\/civ963","article-title":"Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe","volume":"62","author":"Hofstra","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2016.12.019_bb0105","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/cid\/cit697","article-title":"Resistance to HIV integrase strand transfer inhibitors among clinical specimens in the United States, 2009\u20132012","volume":"58","author":"Hurt","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.meegid.2016.12.019_bb0110","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.antiviral.2008.06.012","article-title":"Selection of diverse and clinically relevant integrase inhibitor-resistant human immunodeficiency virus type 1 mutants","volume":"80","author":"Kobayashi","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.meegid.2016.12.019_bb0115","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jac\/dkv284","article-title":"Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan","volume":"71","author":"Lai","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0120","doi-asserted-by":"crossref","first-page":"015","DOI":"10.1186\/s12967-015-0734-3","article-title":"Lack of integrase inhibitors associated resistance mutations among HIV-1C isolates","volume":"13","author":"Mulu","year":"2015","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.meegid.2016.12.019_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099390","article-title":"Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades","volume":"9","author":"Neogi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2016.12.019_bb0130","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1093\/jac\/dku190","article-title":"Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV outpatient study (HOPS)","volume":"69","author":"Palella","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1742-4690-6-49","article-title":"Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach","volume":"6","author":"Paraskevis","year":"2009","journal-title":"Retrovirology"},{"key":"10.1016\/j.meegid.2016.12.019_bb0140","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/jmv.21797","article-title":"Characteristics of HIV-1 non-B subtype infections in Northwest Poland","volume":"82","author":"Parczewski","year":"2010","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2016.12.019_bb0145","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/1471-2334-12-368","article-title":"HIV-1 integrase resistance among antiretroviral treatment naive and experienced patients from Northwestern Poland","volume":"12","author":"Parczewski","year":"2012","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.meegid.2016.12.019_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031674","article-title":"HIV-1 subtype D infections among caucasians from Northwestern Poland-phylogenetic and clinical analysis","volume":"7","author":"Parczewski","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.meegid.2016.12.019_bb0155","doi-asserted-by":"crossref","first-page":"18929","DOI":"10.7448\/IAS.17.1.18929","article-title":"Transmitted drug resistance to rilpivirine among antiretroviral-naive patients living with HIV from northern Poland","volume":"17","author":"Parczewski","year":"2014","journal-title":"J. Int. AIDS Soc."},{"key":"10.1016\/j.meegid.2016.12.019_bb0160","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/jac\/dku372","article-title":"Transmitted HIV drug resistance in antiretroviral-treatment-naive patients from Poland differs by transmission category and subtype","volume":"70","author":"Parczewski","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"year":"2016","series-title":"Principles of Care for the HIV-infected Patients 2016 (in Polish) [Zasady opieki nad osobami zaka\u017conymi HIV 2016]","author":"Polish Scientific AIDS Society","key":"10.1016\/j.meegid.2016.12.019_bb0165"},{"key":"10.1016\/j.meegid.2016.12.019_bb0170","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2105-14-317","article-title":"Automated analysis of phylogenetic clusters","volume":"14","author":"Ragonnet-Cronin","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.meegid.2016.12.019_bb0175","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/infdis\/jiv758","article-title":"Transmission of non-B HIV subtypes in the United Kingdom is increasingly driven by large non-heterosexual transmission clusters","volume":"213","author":"Ragonnet-Cronin","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2016.12.019_bb0180","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1089\/aid.2012.0314","article-title":"High percentage of recent HIV infection among HIV-positive individuals newly diagnosed at voluntary counseling and testing sites in Poland","volume":"29","author":"Rosinska","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"key":"10.1016\/j.meegid.2016.12.019_bb0185","first-page":"1","article-title":"Bayesian evidence synthesis to estimate HIV prevalence in men who have sex with men in Poland at the end of 2009","author":"Rosinska","year":"2015","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.meegid.2016.12.019_bb0190","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/15284336.2016.1153303","article-title":"Integrase strand transfer inhibitors (INSTIs) resistance mutations in HIV-1 infected Turkish patients","volume":"17","author":"Sayan","year":"2016","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.meegid.2016.12.019_bb0195","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/infdis\/jiw165","article-title":"Successful prevention of transmission of integrase resistance in the Swiss HIV cohort study","volume":"214","author":"Scherrer","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2016.12.019_bb0200","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1002\/jmv.23395","article-title":"Molecular epidemiology of recent HIV-1 infections in southern Poland","volume":"84","author":"Smolen-Dzirba","year":"2012","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.meegid.2016.12.019_bb0205","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3851\/IMP2780","article-title":"Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007\u20132013","volume":"20","author":"Stekler","year":"2015","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.meegid.2016.12.019_bb0210","first-page":"12414","article-title":"Recent trends and patterns in HIV-1 transmitted drug resistance in the United Kingdom","volume":"1","author":"Tostevin","year":"2016","journal-title":"HIV Med."},{"key":"10.1016\/j.meegid.2016.12.019_bb0215","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01474-16","article-title":"Antiviral activity of bictegravir (GS-9883), a novel potent HIV-1 integrase strand transfer inhibitor with an improved resistance profile","author":"Tsiang","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2016.12.019_bb0220","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jviromet.2008.07.008","article-title":"A genotypic assay for the amplification and sequencing of integrase from diverse HIV-1 group M subtypes","volume":"153","author":"Van Laethem","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.meegid.2016.12.019_bb0225","first-page":"132","article-title":"2015 Update of the drug resistance mutations in HIV-1","volume":"23","author":"Wensing","year":"2015","journal-title":"Top Antivir. Med."},{"issue":"Suppl. 2","key":"10.1016\/j.meegid.2016.12.019_bb0230","first-page":"1","article-title":"British HIV association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2012","volume":"13","author":"Williams","year":"2012","journal-title":"HIV Med."},{"key":"10.1016\/j.meegid.2016.12.019_bb0235","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/QAI.0000000000000057","article-title":"A randomized, double-blind comparison of single-tablet regimen elvitegravir\/cobicistat\/emtricitabine\/tenofovir DF versus single-tablet regimen efavirenz\/emtricitabine\/tenofovir DF for initial treatment of HIV-1 infection: analysis of week 144 results","volume":"65","author":"Wohl","year":"2014","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.meegid.2016.12.019_bb0240","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00705-013-1933-y","article-title":"Different trends of transmitted HIV-1 drug resistance in Madrid, Spain, among risk groups in the last decade","volume":"159","author":"Yebra","year":"2014","journal-title":"Arch. Virol."},{"key":"10.1016\/j.meegid.2016.12.019_bb0245","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/AAC.03909-14","article-title":"Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection","volume":"59","author":"Yoshinaga","year":"2015","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134816305482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134816305482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T20:41:41Z","timestamp":1658263301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134816305482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":49,"alternative-id":["S1567134816305482"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2016.12.019","relation":{},"ISSN":["1567-1348"],"issn-type":[{"type":"print","value":"1567-1348"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in the integrase and reverse transcriptase transmitted resistance patterns in Northern Poland","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2016.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}